Symptoms in Women, Severe Events in Men: Sex Differences in Adverse Event Reporting for Analgesic and Anti-Inflammatory Medicines Across 2,634,554 Reports
DOI:
https://doi.org/10.64813/ejmr.2026.076Keywords:
Pharmacovigilance, Anti-Inflammatory agents, Non-steroidal, Analgesics, Opioid, Adrenal cortex hormones, Adverse eventsAbstract
Sex differences in drug safety are usually studied one drug at a time, which cannot distinguish a class-specific effect from a general property of how adverse events are reported. We examined three analgesic and anti-inflammatory classes under a single design, against a baseline derived from four previously analysed classes. Case/non-case disproportionality analysis of the FDA Adverse Event Reporting System via openFDA database. All reports listing an NSAID, opioid agonist or corticosteroid with a recorded patient sex were included. Comparisons were made within each class, holding drug exposure constant. Reporting odds ratios (RORs) for women versus men were calculated for 28 pre-specified Preferred Terms with Benjamini-Hochberg control of the false discovery rate. 2,634,554 reports were analysed. Male reports were more often serious in all three classes (all p < 0.001). The death ROR was 0.63, 0.70 and 0.61; pooled with four previously analysed classes it ranged 0.60 to 0.70 across seven unrelated classes (mean 0.637, SD 0.035). Against this baseline, women disproportionately reported symptomatic events and men structural ones: for NSAIDs, nausea (ROR 1.91) and abdominal pain (1.43) versus gastrointestinal haemorrhage (0.56) and myocardial infarction (0.54). Opioid outcomes separated by route of harm, with falls (1.69) in women and drug abuse (0.39) in men. Corticosteroid osteoporosis showed the largest female excess observed (2.16, 95% CI 2.04-2.28). A severity asymmetry invariant across seven classes underlies sex-stratified reporting and must be accounted for before class-specific signals are read. Opioids replicate a therapeutic-use versus misuse separation previously seen with benzodiazepines.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sameer Zafar, Maria Irshad Chohan

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.